- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-18-0065745

Nirvvan Lifescience Private Limited
About Nirvvan Lifescience Private Limited
Data last updated:
Nirvvan Lifescience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC355625. Its GSTIN is 27AAHCN4473A1ZL (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Alkesh Parmanand Dixit and Akhil Parmanand Dixit.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat 3103 Redwood 7 Runwal Green M.G. Link Road, Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.76 Cr, a decline of 20% compared to the previous year. For the same year it recorded a net profit of ₹8.47 Lakh (net margin 0.3%) and EBITDA of ₹15.91 Lakh (EBITDA margin 0.5%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years.
Nirvvan Lifescience Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0065745).
Recognitions & Rankings of Nirvvan Lifescience
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFlat 3103 Redwood 7 Runwal Green M.G. Link Road, Mumbai, Maharashtra, India – 400078
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nirvvan Lifescience Private Limited
The main business activity of Nirvvan Lifescience is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nirvvan Lifescience Private Limited FY 2024 filings available
Nirvvan Lifescience Private Limited reported revenue of ₹31.76 Cr (down 20% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nirvvan Lifescience Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 29% over three years, including a 20% fall in the latest year. EBITDA fell 15% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nirvvan Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.91 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹8.47 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nirvvan Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nirvvan Lifescience are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Nirvvan Lifescience Private Limited
Nirvvan Lifescience has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Alkesh Parmanand Dixit | Director | 22 Feb 2021 | 5 Years 7 Months | Current |
| Akhil Parmanand Dixit | Director | 22 Feb 2021 | 5 Years 7 Months | Current |
| Manju Parmanand Dixit | Director | 22 Feb 2021 | 5 Years 7 Months | Current |
| Parmanand Rajjanlal Dixit | Director | 06 Apr 2021 | 5 Years 6 Months | Current |
Peer Comparison of Nirvvan Lifescience Private Limited
Nirvvan Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mento Vinimay Pvt.Ltd. | ₹32.25 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Siliguri, West Bengal, India |
| Shubh Medicorp (India) Private Limited | ₹32.12 Cr (FY 2024) | •••• | •••• | -24.0% | •••• | Pune, Maharashtra, India |
| Push Logistics and Warehousing Private Limited | ₹32.11 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Mumbai, Maharashtra, India |
| Thistle Healthcare India Private Limited | ₹31.89 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Kozhikode, Kerala, India |
| GSK Pharma India Private Limited | ₹31.87 Cr (FY 2025) | •••• | •••• | 49.0% | •••• | Mumbai, Maharashtra, India |
| Nirvvan Lifescience Private Limited this company | ₹31.76 Cr (FY 2025) | •••• | •••• | -20.0% | •••• | Mumbai, Maharashtra, India |
| Arlak Biotech Private Limited | ₹31.65 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Zirakpur, Punjab, India |
| Rare Metabolics Life-Sciences Private Limited | ₹31.63 Cr (FY 2024) | •••• | •••• | 443.0% | •••• | New Delhi, Delhi, India |
| Rusan Health Care Private Limited | ₹31.6 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
| Gpho Private Limited | ₹31.56 Cr (FY 2025) | •••• | •••• | 140.0% | •••• | Hyderabad, Telangana, India |
| Dadha Pharma Private Limited | ₹31.45 Cr (FY 2022) | •••• | •••• | 248.0% | •••• | Chennai, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Nirvvan Lifescience by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nirvvan Lifescience Private Limited
Nirvvan Lifescience Private Limited is audited by Rahul Thakkar & Associates for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Rahul Thakkar & Associates | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Nirvvan Lifescience Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nirvvan Lifescience Private Limited
Nirvvan Lifescience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Nirvvan Lifescience Private Limited
Nirvvan Lifescience Private Limited has a workforce of 0 employees as of Apr 03, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nirvvan Lifescience Private Limited
Nirvvan Lifescience Private Limited has 5 board changes on record since 2021: 4 appointments and 1 cessation. The latest: Parmanand Rajjanlal Dixit ceased to be Additional Director on 30 Sep 2022.
Credit Ratings, Litigation & Regulatory Alerts for Nirvvan Lifescience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Nirvvan Lifescience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nirvvan Lifescience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nirvvan Lifescience Private Limited
Nirvvan Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCN4473A1ZL | Maharashtra | Active | 02 Mar 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nirvvan Lifescience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nirvvan Lifescience Private Limited
Nirvvan Lifescience is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 February 2021 (5+ years old) and is registered under CIN U24290MH2021PTC355625.
Nirvvan Lifescience reported revenue of ₹31.76 Cr for FY 2025 (down 20% YoY).
Nirvvan Lifescience has 4 current directors:
- Alkesh Parmanand Dixit - Director
- Akhil Parmanand Dixit - Director
- Manju Parmanand Dixit - Director
- Parmanand Rajjanlal Dixit - Director
Nirvvan Lifescience reported a net profit of ₹8.47 Lakh (net margin 0.3%) and EBITDA of ₹15.91 Lakh (EBITDA margin 0.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nirvvan Lifescience is -29% over three years. In the latest year (FY 2025) revenue fell 20%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nirvvan Lifescience is 27AAHCN4473A1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nirvvan Lifescience is U24290MH2021PTC355625. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nirvvan Lifescience was incorporated on 22 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nirvvan Lifescience by revenue are Mento Vinimay Pvt.Ltd, Shubh Medicorp (India) Private Limited, Push Logistics and Warehousing Private Limited, Thistle Healthcare India Private Limited, GSK Pharma India Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Parmanand Rajjanlal Dixit ceased to be Additional Director on 30 Sep 2022. Parmanand Rajjanlal Dixit was appointed as Director on 06 Apr 2021. Akhil Parmanand Dixit was appointed as Director on 22 Feb 2021. Nirvvan Lifescience has 5 board changes on record in total.
Yes, Nirvvan Lifescience is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-18-0065745).